Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1999
11/16/1999US5986048 Process for obtaining insulin precursors having correctly bonded cystine bridges
11/16/1999US5986047 Peptides that bind to the erythropoietin receptor
11/16/1999US5986043 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
11/16/1999US5985938 Method for reducing oxalate
11/16/1999US5985891 Use of virginiamycin to control the passage of carbohydrates into the gastrointestinal tract and the fermentation of these carbohydrates therein, controlling the accumulation of acid in the digestive tract
11/16/1999US5985877 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer
11/16/1999US5985863 Compositions and methods for decreasing IGIF and IFN-γ production by administering an ICE inhibitor
11/16/1999US5985857 Generating stable protein-sugar post-amadori advanced glycation end-product (age) intermediates comprising incubating protein with pentose sugar
11/16/1999US5985855 Treatment of global and focal ischemia using NAALADase inhibitors
11/16/1999US5985854 Prodrugs with enhanced penetration into cells
11/16/1999US5985851 Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof
11/16/1999US5985850 Comprising a therapeutically effective amount of an agent to treat a disease or condition involving underperfused tissue and pathological tissue in humans and a form of hyaluronic acid as transport agent
11/16/1999US5985839 Treating cancer, psoriasis, acne
11/16/1999US5985837 Cell growth inhibitor peptides; treating cancer in a mammal
11/16/1999US5985835 Desmopressin for nocturia, incontinence and enuresis
11/16/1999US5985834 Nova- and decapeptides in the preparation of a drug for the treatment of aids
11/16/1999US5985833 Thrombin inhibitor
11/16/1999US5985832 Inhibiting osteoclastogenesis by administering osteoclast inhibitor protein (oip) to a cell
11/16/1999US5985830 Use of IGF-I for the treatment of kidney disorders
11/16/1999US5985829 Screening assays for compounds that cause apoptosis and related compounds
11/16/1999US5985828 Screening for agonists and antagonists of the receptor ligands, for producing diagnostic or therapeutic reagents, and for producing antibodies
11/16/1999US5985827 Increasing the specificity of a synthetic arg-gly-asp-containing ligand for an arg-gly-asp receptor comprising conformationally restricting the arg-gly-asp sequence by forming a cyclic peptide
11/16/1999US5985825 Methods and compositions for optimization of oxygen transport by cell-free systems
11/16/1999US5985823 Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
11/16/1999US5985822 Relates to peptides comprising at least part of the amino acid sequence of neural cell adhesion molecule (n-cam) and to compositions that utilize these peptides to inhibit dna synthesis and cell division of glial cells
11/16/1999US5985664 Antisense modulation of Sentrin expression
11/16/1999US5985663 Antisense inhibition of interleukin-15 expression
11/16/1999US5985662 By incubating hepatitis b virus or incubating cells, tissues, or a bodily fluid which contains hepatitis b virus with an antisense oligonucleotide of given nucleotide sequences under conditions where viral replication is inhibited
11/16/1999US5985661 Human t-lymphocyte transduced in vitro with a vector comprising genes encoding first and second ribozyme moieties, hte first cleaves hiv-1 rna in the tat gene, and second cleaves hiv-1 rna in a common exon for tat and rev genes
11/16/1999US5985657 Nucleotide sequence coding for human il-1; expression vectors and host cells
11/16/1999US5985656 Human cell line comprising, double negative suppressor cells characterized by specific surface marker pattern, which inhibit the mixed lymphocyte reaction in vitro, but do not kill corresponding target cells; density gradient separation
11/16/1999US5985654 Gene which expresses a protein corresponding to the conserved exposed region of the m6 protein, a virulence factor of streptococcus; poxvirus such as vaccinia containing m6 gene used as vaccines against streptococcal infection
11/16/1999US5985640 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same
11/16/1999US5985635 Nucleic acids encoding novel human serine/threonine protein kinases
11/16/1999US5985633 Human manganese superoxide dismutase proteins
11/16/1999US5985631 Method for preventing the activation of inactive, recombinant Helicobacter pylori apourease
11/16/1999US5985621 Capable of cleaving a rna
11/16/1999US5985620 Polynucleotide
11/16/1999US5985616 Chimeric mammalian NPY Y5 receptors
11/16/1999US5985614 Polynucleotides encoding interleukin-19
11/16/1999US5985613 Use of an "immunodeficiency-virus suppressing lymphokine (ISL) "to inhibit the replication of viruses, in particular of retroviruses
11/16/1999US5985611 Culturing animal cells; transformation with gene expression; recovering
11/16/1999US5985608 Actin-binding polypeptides and nucleic acids encoding the same
11/16/1999US5985606 Human preprotachykinin B
11/16/1999US5985604 Polynucleotide
11/16/1999US5985601 Isolated polynucleotide
11/16/1999US5985599 Nucleic acid encoding a protein capable of binding to immunoglobulin
11/16/1999US5985598 TCL-1 gene and protein and related methods and compositions
11/16/1999US5985592 Uses for pentoxifylline or functional derivatives/metabolites thereof
11/16/1999US5985589 Dna sequences
11/16/1999US5985586 Methods for identifying compounds that modulate the activity of human N-methyl-D-aspartate receptors
11/16/1999US5985585 Competitive binding; detection
11/16/1999US5985583 Hybridization; measurement signal transduction
11/16/1999US5985564 Inhibitor of chromosome segregation
11/16/1999US5985558 Antisense oligonucleotide compositions and methods for the inibition of c-Jun and c-Fos
11/16/1999US5985553 erbB-2 gene segments, probes, recombinant DNA and kits for detection
11/16/1999US5985547 Detection of a mutation in the HLA-DMβ gene in an immunocompromised patient
11/16/1999US5985334 Contacting test compound to receptor from rat brain tissue that binds 6-acetyl-4-benzamido-3-hydroxy-2,2-dimethylbenzopyran derivatives
11/16/1999US5985332 Hemoglobins provided with ligands protecting the oxygen binding sites for use as artificial oxygen carriers for direct application in medicine and biology, and method for the preparation thereof
11/16/1999US5985331 Methods of use of phthalocyanines to inactivate blood borne parasites
11/16/1999US5985321 Soft gelatin capsule manufacture
11/16/1999US5985320 Drug delivery; medical diagnosis; genetic engineering; administering agent that interacts with cell surface receptors
11/16/1999US5985309 Preparation of particles for inhalation
11/16/1999US5985305 Sustained delivery of an active agent using an implantable system
11/16/1999US5985292 Active phospholipids as a vector for active molecules
11/16/1999US5985287 Compounds and methods for treatment and diagnosis of mycobacterial infections
11/16/1999US5985286 Adenyl cyclase-hemolysin (ac-hly) protein,
11/16/1999US5985283 Adenovirus E1A-Associated protein BS69, inhibitor of E1A-transactivation
11/16/1999US5985280 Diagnosis and/or therapy of tumours using monoclonal antibodies specific for the human IL-4 receptor
11/16/1999US5985279 Humanized antibody against CD18
11/16/1999US5985278 Anti-αV-integrin monoclonal antibody
11/16/1999US5985277 Useful for diagnosis and treatement of corynebacterium infections and diseases.
11/16/1999US5985276 Destruction of contaminating tumor cells in stem cell transplants using bispecific antibodies
11/16/1999US5985275 β-Lactoglobulin modified with aromatic anhydride compound for preventing HIV infection
11/16/1999US5985272 Human myeloperoxidase and its therapeutic application
11/16/1999US5985271 Prophylactic and theraputic treatment of group A streptococcal infection
11/16/1999US5985270 Antitumor
11/16/1999US5985268 Gamma-irradiated bacterial preparation having anti-tumor activity
11/16/1999US5985265 Attaching a polyethylene glycol molecule to a consensus interferon molecule via reductive alkylation.
11/16/1999US5985263 Substantially pure histidine-linked protein polymer conjugates
11/16/1999US5985262 Method of treatment with epithelium derived T-cell factor
11/16/1999US5985261 Use of thioredoxin-like molecules for induction of MnSOD to treat oxidative damage
11/16/1999US5985260 Disinfection of blood and biologicals with active albumin-iodine complex
11/16/1999US5985248 Preparing dry powders having hydrophobic and hydrophilic components
11/16/1999US5985242 Peptide of 3 to 5 d-amino acids; may be modified at amino-and/or carboxy terminus; for treatment of amyloidosis, alzheimer's disease
11/16/1999US5985241 Diagnostic and radiodiagnostic agents, formed by reacting technetium-99m with a somatostatin receptor-binding peptide
11/16/1999US5985240 Labeling somatostatin-derived peptides with perrhenate, treating rheumatoid arthritis,
11/16/1999US5984906 Syringe system
11/16/1999CA2088600C Herpes simplex virus vp16 vaccines
11/16/1999CA2078118C Cc-1065 analogs
11/16/1999CA2056402C Therapeutic agent
11/16/1999CA2037900C Pokeweed antiviral protein - monoclonal antibody conjugates
11/16/1999CA2031746C Formulated medicines for enhancing the efficacy of beta-lactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria
11/16/1999CA1340824C Neurokinin a antagonists
11/16/1999CA1340823C Insulin precursors, process for their preparation and process for the preparation of human insulin
11/13/1999CA2248987A1 Novel compounds
11/11/1999WO1999057565A2 Methods for diagnosing and evaluating cancer
11/11/1999WO1999057320A1 Antisense modulation of cd40 expression
11/11/1999WO1999057303A1 A method for diagnosing and treating chronic pelvic pain syndrome
11/11/1999WO1999057295A1 Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof